Question: What upstream chromatin/epitranscriptome/APA marks or genes govern age-resilience of Vmem, mechanotransduction, H3K27ac ‘entropy’, and transcript/splicing entropy?
I’m trying to ask a more regulatory / upstream question about aging resilience:
Across multiple modalities, aging looks like loss of tight regulation / increased entropy (Vmem heterogeneity, mechanotransduction drift, H3K27ac peak erosion, splicing noise, cryptic splice sites, alternative isoforms that ‘shouldn’t’ exist).
The question
What are the most upstream regulators — genes and/or regulatory marks — that control a cell’s sensitivity/resilience to these aging-associated breakdowns?
Specifically I’m interested in upstream factors/marks that influence one or more of:
- Maintaining membrane potential (Vmem) with age (low drift / low heterogeneity)
- Mechanotransduction fidelity with age
- Maintaining H3K27ac distribution (reducing increases in ‘entropy’/peak erosion)
- Maintaining transcript integrity (reducing transcriptomic noise)
- Maintaining splicing fidelity (reducing cryptic splice sites / aberrant isoforms)
And I’m explicitly asking about:
- genes (master regulators, chromatin remodelers, splicing/APA regulators, signaling hubs)
- histone acetylation marks (beyond H3K27ac if relevant)
- epitranscriptome marks (e.g., m6A, pseudouridine, etc.)
- polyadenylation/APA-related marks (CPSF/CSTF machinery, 3’ end processing, 3’UTR usage shifts)
What I’m looking for
-
If you had to nominate the top few upstream levers that are causal (not just correlates), what would they be and why?
-
Any datasets that jointly measure these layers (ATAC/ChIP + RNA isoforms + maybe electrophysiology or mechanotransduction readouts) across age?
-
Evidence from perturbations (CRISPR, small molecules, partial reprogramming) that show restoring upstream regulators reduces downstream entropy increases while maintaining differentiation.
-
How to operationalize “upstream” here: network inference? causal mediation? time-ordering in longitudinal data?
Citations or concrete starting points (specific factors, pathways, or reviews) welcome.
Comments (0)
Sign in to comment.